1. Serum levels of growth factors in patients with urinary bladder cancer
   Şölen Himmetoğlu et al, 2017, Turkish Journal of Biochemistry CrossRef
2. S100B expression in breast cancer as a predictive marker for cancer metastasis
   Meng-Chi Yen et al, 2017, International Journal of Oncology CrossRef
3. Evaluation of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Screening and Monitoring Biomarkers for Brain Metastases
   Su-Hyun Kim et al, 2021, Cancers CrossRef
4. Liquid biopsies to occult brain metastasis
   Asad Ur Rehman et al, 2022, Molecular Cancer CrossRef
5. S100B as a biomarker for brain metastases in patients with non‑small cell lung cancer
   Maria Kondrup et al, 2020, Biomedical Reports CrossRef
6. Serum NSE, MMP‐9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
   Amélie Darlix et al, 2016, International Journal of Cancer CrossRef
7. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
   Amélie Darlix et al, 2016, BMC Cancer CrossRef
8. Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
   Enric Carcereny et al, 2021, Oncotarget CrossRef
9. Association of S100B polymorphisms and serum S100B with risk of systemic lupus erythematous in a Chinese population
   Yulan Lu et al, 2019, Genetics and Molecular Biology CrossRef
10. Coupled Genome-Wide DNA Methylation and Transcription Analysis Identified Rich Biomarkers and Drug Targets in Triple-Negative Breast Cancer
    Maoni Guo et al, 2019, Cancers CrossRef